Polaryx Therapeutics, Inc. (PLYX)
2.09
-0.05
(-2.34%)
USD |
NASDAQ |
Sep 25, 16:00
Polaryx Therapeutics EPS Diluted (Quarterly) : -0.0286 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0286 |
| March 31, 2026 | -0.0539 |
| December 31, 2025 | -0.0316 |
| September 30, 2025 | -0.0302 |
| June 30, 2025 | -0.0213 |
| Date | Value |
|---|---|
| March 31, 2025 | -0.1067 |
| December 31, 2024 | -0.0153 |
| September 30, 2024 | -0.0163 |
| June 30, 2024 | -0.0264 |
| March 31, 2024 | -0.5832 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -0.2295 |
| CNBX Pharmaceuticals, Inc. | -0.0001 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 2.578 |
| Fulcrum Therapeutics, Inc. | -0.3433 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.38M |
| Total Expenses (Quarterly) | 1.38M |
| Enterprise Value | 92.64M |
| Earnings Yield | -6.90% |
| Normalized Earnings Yield | -5.751 |